Literature DB >> 32057707

Peri-coronary inflammation is associated with findings on coronary computed tomography angiography and fractional flow reserve.

Masahiro Hoshino1, Seokhun Yang2, Tomoyo Sugiyama1, Jinlong Zhang2, Yoshihisa Kanaji1, Masao Yamaguchi1, Masahiro Hada1, Yohei Sumino1, Tomoki Horie1, Kai Nogami1, Hiroki Ueno1, Toru Misawa1, Eisuke Usui1, Tadashi Murai1, Tetsumin Lee3, Taishi Yonetsu3, Tsunekazu Kakuta4.   

Abstract

PURPOSE: Peri-coronary adipose tissue attenuation expressed by fat attenuation index (FAI) on coronary CT angiography (CCTA) reflects peri-coronary inflammation and is associated with cardiac mortality. We aimed to investigate the association between FAI and whole vessel and lesion plaque quantification on CCTA in stable patients with intermediate epicardial stenosis evaluated by fractional flow reserve (FFR).
METHODS: A total of 187 left anterior descending arteries (LAD) with intermediate stenosis who underwent FFR measurement and CCTA were studied. FAI was assessed by the crude analysis of the mean CT attenuation value of LAD on CCTA. Determinants of FAI and FFR were explored. Furthermore, the impact of combined baseline data, CCTA-derived lesion plaque assessment, whole vessel quantification, cardiac mass and FAI on discrimination efficacy for ischemia was evaluated as FFR used for a reference standard.
RESULTS: The mean FAI and the median FFR values were -73.0 and 0.77, respectively. Multivariate analysis revealed that male, CCTA-derived positive remodeling, lower minimum lumen area, higher target vessel total cardiac mass, and lower FFR were independent predictors of FAI. CCTA-derived two-dimensional and three-dimensional analysis and FAI were independently and significantly associated with FFR values. Net reclassification index and integrated discrimination improvement index were both significantly improved when FAI was added to the baseline model for lesions with FFR <0.75, but not for FFR≤0.80.
CONCLUSIONS: FAI was associated with FFR, CCTA-derived two-dimensional and three-dimensional lumen and plaque quantification and cardiac mass in patients with intermediate lesions in LAD, indicating that comprehensive CTA assessment may provide risk-stratification.
Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Coronary CT angiography; Coronary artery disease; Fractional flow reserve; Ischemia

Year:  2020        PMID: 32057707     DOI: 10.1016/j.jcct.2020.02.002

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  6 in total

1.  The Perivascular Fat Attenuation Index Improves the Diagnostic Performance for Functional Coronary Stenosis.

Authors:  Hankun Yan; Na Zhao; Wenlei Geng; Zhihui Hou; Yang Gao; Bin Lu
Journal:  J Cardiovasc Dev Dis       Date:  2022-04-23

Review 2.  Assessing Cardiovascular Risk by Using the Fat Attenuation Index in Coronary CT Angiography.

Authors:  Laura V Klüner; Evangelos K Oikonomou; Charalambos Antoniades
Journal:  Radiol Cardiothorac Imaging       Date:  2021-02-25

3.  Influence of Different Segmentations on the Diagnostic Performance of Pericoronary Adipose Tissue.

Authors:  Didi Wen; Rui An; Shushen Lin; Wangwei Yang; Yuyang Jia; Minwen Zheng
Journal:  Front Cardiovasc Med       Date:  2022-03-03

4.  The correlation of pericoronary adipose tissue with coronary artery disease and left ventricular function.

Authors:  Deshu You; Haiyang Yu; Zhiwei Wang; Xiaoyu Wei; Xiangxiang Wu; Changjie Pan
Journal:  BMC Cardiovasc Disord       Date:  2022-09-06       Impact factor: 2.174

Review 5.  The Emerging Role of CT-Based Imaging in Adipose Tissue and Coronary Inflammation.

Authors:  Jeremy Yuvaraj; Kevin Cheng; Andrew Lin; Peter J Psaltis; Stephen J Nicholls; Dennis T L Wong
Journal:  Cells       Date:  2021-05-13       Impact factor: 6.600

Review 6.  Inflammation in Coronary Microvascular Dysfunction.

Authors:  Marios Sagris; Panagiotis Theofilis; Alexios S Antonopoulos; Evangelos Oikonomou; Christina Paschaliori; Nikolaos Galiatsatos; Kostas Tsioufis; Dimitris Tousoulis
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.